Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial

Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T18:27:00.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces that NIH content is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-24T19:22:57.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T20:28:47.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov study page is showing a 403 Forbidden response instead of its study content.
    Difference
    0.2%
    Check dated 2026-10-10T20:43:35.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The study record view displays a 403 Forbidden message and a Home link instead of study details.
    Difference
    0.5%
    Check dated 2026-10-03T20:46:11.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. The header and navigation remain visible while the detailed trial information is not accessible.
    Difference
    17%
    Check dated 2026-09-19T21:59:33.000Z thumbnail image

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.